These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8587511)

  • 21. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 22. A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas aeruginosa.
    Sawa T; Wiener-Kronish JP
    Anesthesiol Clin North Am; 2004 Sep; 22(3):591-606, viii-ix. PubMed ID: 15325721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of the Yersinia pestis phage on the plague envelope antigen and the human erythrocytes.
    Kunikowska D; Głośnicka R
    Bull Inst Marit Trop Med Gdynia; 1985; 36(1-4):103-15. PubMed ID: 3841818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the biological properties of Yersinia pestis during long-term intracellular multiplication].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK
    Mikrobiol Zh (1978); 1988; 50(2):30-3. PubMed ID: 3249571
    [No Abstract]   [Full Text] [Related]  

  • 25. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The aggregation ability of the plague microbe].
    Briukhanova GD; Akiev AK; Beĭer AP
    Med Parazitol (Mosk); 1995; (4):10-4. PubMed ID: 8587509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
    Elvin SJ; Williamson ED
    Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
    [No Abstract]   [Full Text] [Related]  

  • 28. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and type III-dependent secretion of the Yersinia pestis insecticidal-like proteins.
    Gendlina I; Held KG; Bartra SS; Gallis BM; Doneanu CE; Goodlett DR; Plano GV; Collins CM
    Mol Microbiol; 2007 Jun; 64(5):1214-27. PubMed ID: 17542916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The yersiniae--a model genus to study the rapid evolution of bacterial pathogens.
    Wren BW
    Nat Rev Microbiol; 2003 Oct; 1(1):55-64. PubMed ID: 15040180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
    Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
    Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yersinia pestis: still a plague in the 21st century.
    Josko D
    Clin Lab Sci; 2004; 17(1):25-9. PubMed ID: 15011977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals].
    Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of verifying the hypothesis of the constant passage of the plague causative agent on a mathematical model].
    Rudenchik IuV; Soldatkin IS
    Med Parazitol (Mosk); 1976; 45(3):284-9. PubMed ID: 781502
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dependence of block formation in fleas on the characteristics of the carbohydrate metabolism in the plague microbe].
    Kozlov MP; Rozanova GN
    Parazitologiia; 1974; 8(3):254-60. PubMed ID: 4836620
    [No Abstract]   [Full Text] [Related]  

  • 38. [Heterogenetic antigens of plague and cholera microbes, similar to antigens of human and animal tissues].
    Zhukov-Berezhnilov NN; Adamov AK; Anisimov PI; Bochko GM; Podoplelov II
    Biull Eksp Biol Med; 1972 Apr; 73(4):63-5. PubMed ID: 4623967
    [No Abstract]   [Full Text] [Related]  

  • 39. Fimbrial polyadhesins: anti-immune armament of Yersinia.
    Zav'yalov VP
    Adv Exp Med Biol; 2012; 954():183-201. PubMed ID: 22782763
    [No Abstract]   [Full Text] [Related]  

  • 40. [A comparative cytofluorimetric analysis of the blood leukocytes in guinea pigs exposed to the phospholipase D and antigens of the causative agent of plague].
    Sinichkina NA; Kravtsov AL; Naumov AV; Kuz'michenko IA; Taranenko TM; Zadumina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):52-4. PubMed ID: 1301664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.